HRP20110430T1 - Fsh glikozilacijski mutant - Google Patents
Fsh glikozilacijski mutant Download PDFInfo
- Publication number
- HRP20110430T1 HRP20110430T1 HR20110430T HRP20110430T HRP20110430T1 HR P20110430 T1 HRP20110430 T1 HR P20110430T1 HR 20110430 T HR20110430 T HR 20110430T HR P20110430 T HRP20110430 T HR P20110430T HR P20110430 T1 HRP20110430 T1 HR P20110430T1
- Authority
- HR
- Croatia
- Prior art keywords
- fsh
- seq
- sequence
- vector
- mutant
- Prior art date
Links
- 230000013595 glycosylation Effects 0.000 title abstract 2
- 238000006206 glycosylation reaction Methods 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 claims abstract 3
- 210000004027 cell Anatomy 0.000 claims 7
- 239000013598 vector Substances 0.000 claims 7
- 239000013604 expression vector Substances 0.000 claims 6
- 102000002287 alpha Subunit Glycoprotein Hormones Human genes 0.000 claims 4
- 108010000732 alpha Subunit Glycoprotein Hormones Proteins 0.000 claims 4
- 102000035824 beta Subunit Follicle Stimulating Hormone Human genes 0.000 claims 4
- 108010081485 beta Subunit Follicle Stimulating Hormone Proteins 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 1
- 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000021267 infertility disease Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 230000001186 cumulative effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49980203P | 2003-09-02 | 2003-09-02 | |
PCT/US2004/029042 WO2005020934A2 (fr) | 2003-09-02 | 2004-09-02 | Mutant de la fsh a glycosylation |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20110430T1 true HRP20110430T1 (hr) | 2011-07-31 |
Family
ID=34272871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20110430T HRP20110430T1 (hr) | 2003-09-02 | 2011-06-08 | Fsh glikozilacijski mutant |
Country Status (24)
Country | Link |
---|---|
US (1) | US7700112B2 (fr) |
EP (1) | EP1694271B1 (fr) |
JP (1) | JP4653090B2 (fr) |
KR (1) | KR101099809B1 (fr) |
CN (1) | CN1984926B (fr) |
AT (1) | ATE511829T1 (fr) |
AU (1) | AU2004268683B2 (fr) |
BR (1) | BRPI0413206A (fr) |
CA (1) | CA2535522A1 (fr) |
CY (1) | CY1112439T1 (fr) |
DK (1) | DK1694271T3 (fr) |
EA (1) | EA012175B1 (fr) |
ES (1) | ES2367784T3 (fr) |
HK (1) | HK1101315A1 (fr) |
HR (1) | HRP20110430T1 (fr) |
IL (1) | IL174037A0 (fr) |
MX (1) | MXPA06002119A (fr) |
NO (1) | NO20061446L (fr) |
PL (1) | PL1694271T3 (fr) |
PT (1) | PT1694271E (fr) |
SI (1) | SI1694271T1 (fr) |
UA (1) | UA88879C2 (fr) |
WO (1) | WO2005020934A2 (fr) |
ZA (1) | ZA200601803B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE038947T2 (hu) | 2005-08-26 | 2018-12-28 | Ares Trading Sa | Eljárás glikozilált béta-interferon elõállítására |
WO2007065918A2 (fr) * | 2005-12-09 | 2007-06-14 | Ares Trading S.A. | Procede de purification de la fsh ou d’un mutant de la fsh |
BRPI0620223A2 (pt) * | 2005-12-22 | 2011-11-01 | Serono Lab | mutantes de fsh |
RS51792B (en) * | 2006-01-17 | 2011-12-31 | Merck Serono Sa. | NEW FSH WITH GLYCOSILATION OPTION D3N |
WO2008116867A1 (fr) * | 2007-03-26 | 2008-10-02 | Novartis Ag | Biomarqueurs rénaux prédictifs sûrs et signatures de biomarqueurs pour surveiller la fonction rénale |
AR081755A1 (es) | 2010-04-02 | 2012-10-17 | Hanmi Holdings Co Ltd | Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo |
CN108676096B (zh) * | 2018-05-22 | 2022-03-29 | 北京伟杰信生物科技有限公司 | 重组猪fsh-ctp融合蛋白及其制备方法与应用 |
EP4055038A4 (fr) * | 2019-11-06 | 2023-11-15 | The Regents of the University of Colorado, a body corporate | Hormone de stimulation folliculaire modifiée et procédés d'utilisation associés |
CN114213523B (zh) * | 2021-11-15 | 2024-07-09 | 广州源博医药科技有限公司 | 一种用于重组蛋白的高糖基化修饰序列及其重组猪促卵泡激素和应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4840896A (en) | 1983-11-02 | 1989-06-20 | Integrated Genetics, Inc. | Heteropolymeric protein |
US5639639A (en) | 1983-11-02 | 1997-06-17 | Genzyme Corporation | Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof |
US4923805A (en) | 1983-11-02 | 1990-05-08 | Integrated Genetics, Inc. | Fsh |
US5156957A (en) | 1983-11-02 | 1992-10-20 | Genzyme Corporation | Follicle stimulating hormone |
US4845077A (en) | 1984-04-03 | 1989-07-04 | Serono Laboratories, Inc. | Method of inducing ovulation |
US4589402A (en) | 1984-07-26 | 1986-05-20 | Serono Laboratories, Inc. | Method of in vitro fertilization |
US5338835A (en) | 1989-02-21 | 1994-08-16 | Washington University | CTP-extended form of FSH |
ATE148171T1 (de) | 1989-02-21 | 1997-02-15 | Univ Washington | Modifizierte formen von fortpflanzungshormonen |
US5508261A (en) | 1991-06-18 | 1996-04-16 | University Of Medicine & Dentistry Of New Jersey | Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same |
US6407205B1 (en) * | 1997-06-04 | 2002-06-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | FSH-releasing peptides |
ES2247710T3 (es) * | 1997-06-20 | 2006-03-01 | Akzo Nobel N.V. | Antagonista de gonadotropina. |
US6235755B1 (en) * | 1998-08-07 | 2001-05-22 | Applied Research Systems Ars Holding N.A. | FSH mimetics for the treatment of infertility |
EP1442748A1 (fr) * | 2000-01-27 | 2004-08-04 | Applied Research Systems ARS Holding N.V. | Utilisation de FSH pour traiter l'infertilité |
US20020127652A1 (en) * | 2000-02-11 | 2002-09-12 | Schambye Hans Thalsgard | Follicle stimulating hormones |
WO2001058493A1 (fr) | 2000-02-11 | 2001-08-16 | Maxygen Aps | Conjugates of follicle stimulating hormones |
AU2002368265B2 (en) | 2001-10-22 | 2007-06-07 | Merck Serono Sa | Mutant glycoproteins |
-
2004
- 2004-02-09 UA UAA200603350A patent/UA88879C2/ru unknown
- 2004-09-02 SI SI200431701T patent/SI1694271T1/sl unknown
- 2004-09-02 KR KR1020067004084A patent/KR101099809B1/ko not_active IP Right Cessation
- 2004-09-02 ZA ZA200601803A patent/ZA200601803B/en unknown
- 2004-09-02 WO PCT/US2004/029042 patent/WO2005020934A2/fr active Application Filing
- 2004-09-02 DK DK04783331.4T patent/DK1694271T3/da active
- 2004-09-02 JP JP2006525513A patent/JP4653090B2/ja not_active Expired - Fee Related
- 2004-09-02 CA CA002535522A patent/CA2535522A1/fr not_active Abandoned
- 2004-09-02 EP EP04783331A patent/EP1694271B1/fr not_active Expired - Lifetime
- 2004-09-02 AU AU2004268683A patent/AU2004268683B2/en not_active Ceased
- 2004-09-02 BR BRPI0413206-8A patent/BRPI0413206A/pt not_active IP Right Cessation
- 2004-09-02 CN CN2004800326655A patent/CN1984926B/zh not_active Expired - Fee Related
- 2004-09-02 AT AT04783331T patent/ATE511829T1/de active
- 2004-09-02 MX MXPA06002119A patent/MXPA06002119A/es active IP Right Grant
- 2004-09-02 ES ES04783331T patent/ES2367784T3/es not_active Expired - Lifetime
- 2004-09-02 US US10/934,707 patent/US7700112B2/en not_active Expired - Fee Related
- 2004-09-02 PL PL04783331T patent/PL1694271T3/pl unknown
- 2004-09-02 PT PT04783331T patent/PT1694271E/pt unknown
- 2004-09-02 EA EA200600526A patent/EA012175B1/ru not_active IP Right Cessation
-
2006
- 2006-03-01 IL IL174037A patent/IL174037A0/en unknown
- 2006-03-30 NO NO20061446A patent/NO20061446L/no not_active Application Discontinuation
-
2007
- 2007-08-30 HK HK07109465.0A patent/HK1101315A1/xx not_active IP Right Cessation
-
2011
- 2011-06-08 HR HR20110430T patent/HRP20110430T1/hr unknown
- 2011-07-19 CY CY20111100704T patent/CY1112439T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE511829T1 (de) | 2011-06-15 |
CN1984926A (zh) | 2007-06-20 |
BRPI0413206A (pt) | 2006-10-03 |
IL174037A0 (en) | 2006-08-01 |
SI1694271T1 (sl) | 2011-08-31 |
CY1112439T1 (el) | 2015-12-09 |
EA012175B1 (ru) | 2009-08-28 |
UA88879C2 (en) | 2009-12-10 |
JP2007508245A (ja) | 2007-04-05 |
PT1694271E (pt) | 2011-07-07 |
KR101099809B1 (ko) | 2011-12-27 |
AU2004268683A2 (en) | 2005-03-10 |
MXPA06002119A (es) | 2006-05-31 |
DK1694271T3 (da) | 2011-09-12 |
ES2367784T3 (es) | 2011-11-08 |
AU2004268683A1 (en) | 2005-03-10 |
US7700112B2 (en) | 2010-04-20 |
EP1694271B1 (fr) | 2011-06-08 |
AU2004268683B2 (en) | 2010-06-24 |
US20050100989A1 (en) | 2005-05-12 |
EP1694271A2 (fr) | 2006-08-30 |
WO2005020934A3 (fr) | 2007-02-15 |
WO2005020934A2 (fr) | 2005-03-10 |
KR20070029620A (ko) | 2007-03-14 |
CN1984926B (zh) | 2012-04-11 |
EA200600526A1 (ru) | 2007-04-27 |
JP4653090B2 (ja) | 2011-03-16 |
HK1101315A1 (en) | 2007-10-12 |
PL1694271T3 (pl) | 2011-11-30 |
CA2535522A1 (fr) | 2005-03-10 |
NO20061446L (no) | 2006-03-30 |
ZA200601803B (en) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20110430T1 (hr) | Fsh glikozilacijski mutant | |
KR100345254B1 (ko) | 생물학적샘플속의인터루킨12또는인터루킨12의p40아단위를검출하는방법 | |
MX9206041A (es) | Proceso para producir interferon inmune humano. | |
DE60329201D1 (de) | Substituierte wt1-peptide | |
ATE319827T1 (de) | Polypeptid, das die differenzierung unterdrueckt | |
BR9813608A (pt) | Polipeptìdeo isolado, sequências de ácido nucleico isolado e mutante, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, processos para produzir uma sequência de ácido nucleico mutante, para produzir um polipeptìdeo, para produzir um mutante de uma célula originária e para produzir uma proteìna, e, célula mutante | |
AR241654A1 (es) | Procedimiento para producir activador de plasminogeno de tejido humano. | |
ES2080809T3 (es) | Receptores de factor de necrosis tumoral alfa y beta. | |
NO177678C (no) | Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein | |
DK0479948T3 (da) | Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder | |
ATE430161T1 (de) | Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung | |
HRP20100340T1 (hr) | Polipeptidi koji imaju antimikrobno djelovanje i polinukleotidi koji ih kodiraju | |
MY167485A (en) | Recombinant human interferon-like proteins | |
EP4276463A3 (fr) | Peptides | |
NZ508816A (en) | Bactericidal/permeability-increasing protein (BPI) deletion analogs | |
MEP37808A (en) | Dna encoding a novel rg1 polypeptide | |
NZ335633A (en) | Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases | |
DE69935599D1 (de) | Modifizierte hcv peptid-impfstoffe | |
HRP20100610T1 (hr) | Nova fsh glikozilacijska varijanta d3n | |
US5358707A (en) | Oxidized variants of GM-CSF | |
ES2127192T3 (es) | Polipeptidos especificos del epididimo y su aplicacion. | |
EP0206200A3 (en) | Human cholinesterase-type proteins and their production | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
ATE496632T1 (de) | Synthetischer impfstoff zur zeckeneindämmung | |
WO2003014293A3 (fr) | Nouveaux analogues de polypeptides et proteines hybrides et leurs procedes d'utilisation |